Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor

Journal of Neurochemistry

Volumn 71, Issue 5, 1998, Pages 2169-2177

  Boess, Frank G ^a   Monsma Jr , Frederick J ^a   Sleight, Andrew J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Adenylyl cyclase; D Lysergic acid diethylamide; Ergopeptines; Serotonin; Serotonin 5 HT6 receptors; Site directed mutagenesis

Indexed keywords

ADENYLATE CYCLASE; LYSERGIDE; SEROTONIN RECEPTOR;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SITE DIRECTED MUTAGENESIS;

EID: 0031722106     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71052169.x     Document Type: Article

References (29)

1. Boess F. G. and Martin I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33, 275-317.
2. 6 receptors stably expressed in HEK293 cells. Neuropharmacology 36, 713-720.
3. 6 receptor. Mol. Pharmacol. 52, 515-523.
4. 6 receptor in the rat brain: a study using antisense oligonucleotides. J. Pharmacol. Exp. Ther. 274, 173-180.
5. 7]-α-MSH at the melanocortin-1 receptor. Biochem. Biophys. Res. Commun. 202, 1266-1271.
6. Fraser C. M., Wang C. D., Robinson D. A., Gocayne J. D., and Venter J. C. (1989) Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol. 36, 840-847.
7. Gantz I., DelValle J., Wang L.-D., Tashiro T., Munzert G., Guo J.-Y., Konda Y., and Yamada T. (1992) Molecular basis for the interaction of histamine with the histamine H2 receptor. J. Biol. Chem. 267, 20840-20843.
8. 6 receptor-like material in the rat central nervous system. Brain Res. 746, 207-219.
9. Hibert M. F., Trumpp-Kallmeyer S., Bruinvels A., and Hoflack J. (1991) Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 40, 8-15.
10. 1A receptor: a site-directed mutagenesis study. FEBS Lett. 312, 259-262.
11. 1adrenergic receptor subtype selective agonist binding. J. Biol. Chem. 270, 23189-23195.
12. Javitch J. A., Fu D., Chen J., and Karlin A. (1995) Mapping the binding-site of the dopamine D2 receptor by the substituted-cysteine accessibility method. Neuron 14, 825-831.
13. Kask K., Berthold M., Kahl U., Nordvall G., and Bartfai T. (1996) Delineation of the peptide binding site of the human galanin receptor. EMBO J. 15, 236-244.
14. 2a adenosine receptor. J. Biol. Chem. 270, 13987-13997.
15. 2 receptor. Eur. J. Pharmacol. 227, 205-214.
16. Monsma F. J., Shen Y., Ward R. P., Hamblin M. W., and Sibley D. R. (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43, 320-327.
17. 1E 5-hydroxytryptamine receptors. J. Neurochem. 67, 2096-2103.
18. Roth B. L., Craigo S. C., Choudhary M. S., Uluer A., Monsma F. J., Shen Y., Meltzer H. Y., and Sibley D. R. (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptor. J. Pharmacol. Exp. Ther. 268, 1403-1410.
19. 6) receptor: molecular cloning, localisation and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193, 269-276.
20. Sakmar T. P., Franke R. R., and Khorana H. G. (1989) Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proc. Natl. Acad. Sci. USA 86, 8309-8313.
21. 1 receptor. Mol. Pharmacol. 50, 285-292.
22. Savarese T. M. and Fraser C. M. (1992) In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 283, 1-19.
23. 7 serotonin receptor subtype. J. Biol. Chem. 268, 18200-18204.
24. 7 receptors: molecular biology, functional correlates and possible therapeutic indications. Drug News Perspect. 10, 214-224.
25. Spalding T. A., Birdsall N. J. M., Curtis C. A. M., and Hulme E. C. (1994) Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors. J. Biol. Chem. 269, 4092-4097.
26. Strader C. D., Sigal I. S., Candelore M. R., Rands E., Hill W. S., and Dixon R. A. F. (1988) Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263, 10267-10271.
27. Wang C.-D., Gallaher T. K., and Shih J. C. (1993) Site-directed mutagenesis of the serotonin 5-hydroxytryptamine, receptor: identification of amino acids necessary for ligand binding and receptor activation. Mol. Pharmacol. 43, 931-940.
28. 2 dopamine receptors: mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide drugs. J. Neurochem. 62, 1664-1669.
29. 1). J. Biol. Chem. 270, 14024-14030.